During a recent investor conference, nutraceutical giant TCI (大江生醫) announced that it is developing a natural GLP-1 supplement inspired by recent pharmaceutical breakthroughs. This product aims to penetrate the international weight management market, with a primary launch scheduled for the Thai market in Q3 2026 through a major global client.

Global Revenue Shift:

• North America: Revenue share rose to 31% (a 5-percentage point increase YoY), driven by high consumer demand for liquid nutrients, liposomal technology, and high-absorption functional formulations.
• Asia-Pacific (Excl. China): Revenue share grew from 24% to 29%, aided by "City Factory" localized production strategies that shorten supply chains and improve delivery efficiency.
• China: Revenue share dropped from 35% to 23%, reflecting intensified competition and a shifting macroeconomic consumption environment.

Resource: 大江新保健品第3季賣向泰國